Pharmaceutical Industry

Page 40 of 100

Biogen Stock Alzheimer's Aducanumab
Newsletters

Biogen Stock Falls After Analyst Throws Cold Water on Its Alzheimer’s Drug Bet

By
December 2, 2019
A boy suffering from dengue fever rests under a mosquito net in a gymnasium
Magazine

Epidemic of fear: How the trouble-ridden debut of a breakthrough vaccine sparked a panic

By
November 26, 2019
Novartis Amarin Cholesterol Drugs
Newsletters

Novartis’ $9.7 Billion Deal Sets off Heart Drug Wars

By
November 25, 2019
American Vasant Narasimhan, CEO of Swiss pharmaceutical and drug maker Novartis speaks during a conference at the Coins2Day Global Forum event in Paris on Nov. 18, 2019. (Photo by ERIC PIERMONT / AFP) (Photo by ERIC PIERMONT/AFP via Getty Images)
International

Novartis Bets Big on Cholesterol Drug With $9.7 Billion Buyout of Medicines Co.

By James Paton and Bloomberg
November 25, 2019
Best Drugs Last 10 Years
Newsletters

Which Medicines Have Transformed Drug Development in the Past Decade?

By
November 22, 2019
Fish Oil Drug to Treat Heart Disease Gets Key Nod for Wider FDA Approval
Politics

Fish Oil Drug to Treat Heart Disease Gets Key Nod for Wider FDA Approval

By Matthew Perrone and The Associated Press
November 15, 2019
BeiGene FDA Approval Cancer
Newsletters

Chinese Biotech BeiGene Makes a Splash in Cancer Treatment With FDA Drug Approval

By
November 14, 2019
CRISPR Gene Editing Cancer Safety
Newsletters

CRISPR Gene-Editing Is Being Used to Fight Cancer—And May Be Safe

By
November 7, 2019
Trump Breaks From Pelosi Medicare Drug Talks, Throws Support Behind Senate Bill
Politics

Trump Breaks From Pelosi Medicare Drug Talks, Throws Support Behind Senate Bill

By Ricardo Alonso-Zaldivar and The Associated Press
November 5, 2019
The Hong Kong skyline is shown at night in a layer of cloudy fog.
Luxury

This 24-Year-Old Chinese Biopharma Heir Just Became an Overnight Billionaire

By Blake Schmidt, Venus Feng, Gregor Stuart Hunter and Bloomberg
October 23, 2019
Biogen Alzheimers Aducanumab
Newsletters

Let’s Talk About Biogen’s Stunning Alzheimer’s Drug Reversal: Brainstorm Health

By
October 23, 2019
fortune logo icon (red)
Newsletters

Could Lowering Drug Prices Hamper Drug Innovation?—Brainstorm Health

By
October 14, 2019
China Biotech Brad Loncar
Newsletters

How China Is Transforming the Biotech Industry: Brainstorm Health

By
October 8, 2019
Nike Innovation For Everybody Unveiling

Nike CEO Mark Parker Knew of Company-Linked Doping Experiments, U.S. Anti-Doping Agency Says

By Eben Novy-Williams and Bloomberg
October 1, 2019
Ken Griffin Citadel Fox Foundation Parkinson's
Health

Exclusive: Billionaire Ken Griffin to Fund $10 Million Parkinson’s Competition With Michael J. Fox Foundation

By
September 23, 2019

Most Popular